Adage Capital Partners
LOGC

Adage Capital Partners’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History

Adage Capital Partners’s Portfolio LOGC Stock Details LOGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-800,000
Closed -$6.77M – 832
2020
Q2 		$6.77M Sell
800,000
-115,355
-13% -$759K 0.02% 577
2020
Q1 		$4.52M Sell
915,355
-331,199
-27% -$2.58M 0.01% 583
2019
Q4 		$8.97M Sell
1,246,554
-131,921
-10% -$1.19M 0.02% 554
2019
Q3 		$14.9M Buy
1,378,475
+78,475
+6% +$839K 0.04% 439
2019
Q2 		$16.9M Buy
1,300,000
+390,000
+43% +$5.18M 0.04% 401
2019
Q1 		$8.99M Hold
910,000
– – 0.02% 540
2018
Q4 		$9.46M Buy
+910,000
New +$11M 0.03% 517

Other funds holding LOGC

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
SC
Samlyn Capital New York $5.82B AUM 36.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return